文献速递主动脉疾病内脏/肾动脉与血管畸形

Zenith 开窗支架中 iCAST 桥接支架的结局:单中心经验

Outcomes of iCAST Bridging Stents in Zenith Fenestrated Endografts - A Single Center Experience.
PubMed 文献 · Ann Vasc Surg · 2025-04-14

该单中心研究纳入2012至2020年207例使用未改造Zenith开窗支架行开窗腔内主动脉修复术(FEVAR)并以iCAST覆膜支架桥接内脏靶血管的患者,评估桥接支架并发症及再干预情况。随访发现23例发生需再干预的桥接支架并发症;并发症组更常使用肱动脉入路(34.8% vs 15.8%,P=0.0251),且更多为IV型胸腹主动脉瘤(TAAA)修复(17.8% vs 5.4%,P=0.0316)。大多数分支并发症在术后2年内发现,半数再干预发生在指数手术后7.5个月内。

要点

  • 207例FEVAR使用未改造ZFEN并以iCAST桥接内脏靶血管,23例发生需再干预的桥接支架并发症。
  • 并发症组肱动脉入路比例高于无并发症组(34.8% vs 15.8%,P=0.0251)。
  • 并发症组IV型TAAA修复比例高于无并发症组(17.8% vs 5.4%,P=0.0316)。

核心结论

  • 本单中心大样本经验报告了使用未改造ZFEN行FEVAR时iCAST分支支架的结局及支架相关并发症的危险因素。
  • 发生分支并发症的患者更可能采用肱动脉入路且动脉瘤修复范围更广泛。
  • 大多数分支并发症在术后2年内发现,半数再干预发生在指数手术后7.5个月内。

研究设计与样本

  • 单中心研究,2012年至2020年共207例患者使用未改造Zenith开窗支架行FEVAR,并以iCAST覆膜支架桥接内脏靶血管。
  • 收集患者人口学与指数修复的术中变量,并长期随访内漏、分支通畅性和再干预情况。
  • 分支支架并发症定义为监测影像确定的需干预的支架错位、扭结、闭塞或内漏。

主要发现

  • 队列以男性为主(n=158,76.3%)、白人为主(n=199,96.1%),并伴心血管合并症。
  • 大多数修复为近肾主动脉瘤(n=149,72%),其余修复向头侧延伸更远。
  • 随访发现23例需再干预的桥接支架并发症。
  • 并发症组肱动脉入路使用率高于无并发症组(34.8% vs 15.8%,P=0.0251)。
  • 并发症组因IV型胸腹主动脉瘤(TAAA)修复的比例高于无并发症组(17.8% vs 5.4%,P=0.0316)。

关键数值与推荐

  • 分支支架并发症定义为监测影像确定的需干预的支架错位、扭结、闭塞或内漏。
  • 原文未报告具体的推荐条款或阈值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate the outcomes of patients undergoing placement of balloon-expandable iCAST bridging stents during fenestrated endovascular aortic aneurysm repair (FEVAR) with Zenith Fenestrated Endografts (ZFENs) and to identify preoperative and perioperative risk factors for stent-related complications. METHODS: Between 2012 and 2020, 207 patients underwent FEVAR using unmodified ZFEN with bridging iCAST-covered stents to visceral target vessels. We collected patient demographics and operative variables from the index repair. We collected long-term follow-up data for endoleaks, branch patency, and reintervention. We defined branch stent complications as malalignment, kinking, occlusion, or endoleak requiring intervention as determined by surveillance imaging studies. We compared variables from the index operation in those patients with stent complications to those patients without stent complications to identify significant risk factors. RESULTS: Patients in our cohort were predominantly male (n = 158, 76.3%), White (n = 199, 96.1%), and demonstrated cardiovascular comorbidity. The majority of repairs were for juxtarenal aortic aneurysms (n = 149, 72%) with the remainder of repairs extending further cephalad. We identified 23 patients with bridging stent complications during follow-up that required reintervention. Brachial access was more frequently used in the complication group (34.8% vs. 15.8%, P = 0.0251). A significantly higher proportion of patients in the complication group was treated for extent IV thoracoabdominal aortic aneurysms (TAAAs) (17.8% vs. 5.4%, P = 0.0316). Additional patient characteristics and perioperative factors are compared between the branch complications and no branch complications groups. An intervention-free patency Kaplan-Meier plot is presented. CONCLUSION: Here, we present a large single institution experience with iCAST branch stents during FEVAR using unmodified ZFEN and risk factors for stent-related complications. Patients with branch complications were more likely to have brachial access and more extensive aneurysm repair. Most branch complications were identified within the first 2 years, with half of reinterventions occurring within 7.5 months of the index operation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wahidi R, Droz N, Jammeh M, et al. Outcomes of iCAST Bridging Stents in Zenith Fenestrated Endografts - A Single Center Experience. Ann Vasc Surg. 2025. PMID: 40233896. doi:10.1016/j.avsg.2025.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。